American Psychiatric Association

New data show ADHD-specific text message intervention beneficial to patients who may have low rate of stimulant treatment adherence.

While treatment options do not impact 30-day readmissions, they can influence hospital length of stay and costs.

Data show effectiveness of DSRM in treating major depressive disorder with less frequent discontinuations.

Late life depression is a known risk factor for dementia, impacting 8-16% in the US.

New data show mental health workers experienced lower levels of traumatic stress and peritraumatic distress during COVID-19 pandemic, compared to healthcare workers and general population.

The transition from pediatric care to adult care can be confusing for ADHD patients, often leading to a discontinuation of health care services altogether.

Despite higher risk of adverse effects in patients with opioid use disorder, benzodiazepine does not undo protection benefits of buprenorphine.

In a poster presented at APA, researchers review current clinical practice guidelines for schizophrenia.

New data show significant therapeutic effects of dextraomethadone treatment in MDD patients below the median percentage of life-years from diagnosis.

A new study from APA 2021 finds algorithm use can reduce clinical misdiagnosis of bipolar disorder as other mood disorders, including major depressive disorder.

The rates of both diseases have been increasingly linked in recent years.

Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.

Children born to mothers who suffered from depression during pregnancy are at a greater risk of adolescent depression and psychosis.

There were no significant differences observed in mood episodes for bipolar patients in either AISR therapy or standard treatment.

Response does not favor more or less baseline symptom severity according to a new study.

Since 2005, opioid use has increased amongst older dementia patients.

Patients with adolescent disruption of cognitive developed had more severe symptoms following a schizophrenia diagnosis.

Investigators are currently working on a new algorithm that can present a time window in which an individual might develop suicidal behavior.

A meta-analysis of the online CBT programs shows promising benefits, with the addition of anonymity for patients.

Jesse Wright, MD, PhD, discusses the convenience of telehealth during the COVID-19 pandemic.

Jesse Wright, MD, PhD, suggests clinicians and patients have a list of triggers and social networks for patients who might be at risk of suicide.

In a virtual APA session, Nora D. Volkow, MD, discusses how vaping can increase the risk of individuals of developing infections from the coronavirus.

An expert projects annual national prevention lifeline calls will reach 3.7 million by 2023.

An analysis of 20-year outpatient prescribing trends show the drug class is being favored over mood stabilizers.

A look at the 3 stages of alcohol abuse and the state of mental health throughout it.

A look at how the antibody influences the pathology of encephalitis, and how it can be properly assessed and treated.

New research shows case fatality rates are increasing for individuals between 20-44 years old.

New federal regulations allows psychiatrists to use popular video conferencing tools like Zoom for telehealth appointments.

Investigators are still looking into the immediate and longterm effects of the virus on the mind.

In an American Psychiatric Association virtual session, Joshua C. Morganstein, MD, stresses routine sleep and exercise is critical for frontline medical workers.